Wai Chun Bio-Technology Limited (0660.HK) HKSE

0.68

+0.01(+1.49%)

Updated at June 03 10:07AM

Currency In HKD

Valuation

Market Cap33.55M
Enterprise Value166.29M
P/E Ratio-17.33
PEG Ratio-0.17
Price/Sales Ratio0.21
Price/Book Ratio-1.88
Enterprise/Revenue0.44
Enterprise/EBITDA17.39

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-0.01
Operating Margin0.01

Management Effectiveness

Return On Assets-0.03
Return On Equity0.09

Income Statement

Revenue568.26M
Revenue/Share3.18
Gross Profit50.53M
EBITDA13.82M
Net Income-6.9M
Diluted EPS-0.04

Balance Sheet

Total Cash5.61M
Total Cash/Share0.03
Total Debt138.35M
Total Debt/Equity-2.17
Current Ratio0.67
Book Value Per Share-0.19

Price History

52-Week Change427.56
52-Week High2.33
52-Week Low0.12
Moving Average 50 Days0.65
Moving Average 200 Days0.32

Statistics

Average Volume1.83M
Shares Outstanding178.48M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateMarch 14, 2023